Table 5.

Number and type of supportive care services provided to ART and pre-ART patients at 43 sites for which data were analyzed. Cotrimoxazole prophylaxis was provided by the greatest number of facilities. Nearly three-fourths of the sites offered TB treatment onsite, and slightly over one-half had programs in place to follow up patients in the community.

Follow-up of patients in the community	23 of 43 (53.5%)
TB treatment available on site	31 of 43 (72.1%)
Oral candidiasis/thrush treated	37 of 43 (86.0%)
Cotrimoxazole regularly provided	42 of 43 (97.7%)
Psychosocial support regularly provided	40 of 43 (93.0%)
Pain management regularly provided	39 of 43 (90.7%)
End-of-life care provided	23 of 43 (53.5%)